<DOC>
	<DOC>NCT00133198</DOC>
	<brief_summary>A 12 week clinical trial was conducted in the United States in order to compare pramipexole (MirapexÂ®) versus placebo for the ability to reduce the symptoms of restless legs syndrome in adult subjects.</brief_summary>
	<brief_title>Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria />
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>